dfmta (Q109767)

From MaRDI portal

!

This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use the normal view instead:

Phase I/II Adaptive Dose-Finding Design for MTA
Language Label Description Also known as
default for all languages
No label defined
    English
    dfmta
    Phase I/II Adaptive Dose-Finding Design for MTA

      Statements

      0 references
      1.7-3
      3 May 2022
      0 references
      PACKAGES.rds
      9 July 2026
      0 references
      1.0-1
      6 November 2014
      0 references
      1.0-3
      20 November 2014
      0 references
      1.0
      5 November 2014
      0 references
      1.1-0
      12 January 2015
      0 references
      1.1-2
      24 January 2015
      0 references
      1.2
      21 April 2015
      0 references
      1.3-1
      27 April 2015
      0 references
      1.3-2
      30 April 2015
      0 references
      1.3-3
      5 October 2015
      0 references
      1.3-4
      21 June 2016
      0 references
      1.4
      27 March 2017
      0 references
      1.5
      22 May 2017
      0 references
      1.6-2
      10 January 2018
      0 references
      1.6
      7 January 2018
      0 references
      1.7-0
      24 May 2018
      0 references
      1.7-1
      31 January 2020
      0 references
      1.7-3
      4 May 2022
      0 references
      1.7-6
      30 September 2024
      0 references
      1.7-8
      2 March 2026
      0 references
      0 references
      Marie-karelle Riviere
      0 references
      Marie-Karelle Riviere
      0 references
      2 March 2026
      0 references
      Phase I/II adaptive dose-finding design for single-agent Molecularly Targeted Agent (MTA), according to the paper "Phase I/II Dose-Finding Design for Molecularly Targeted Agent: Plateau Determination using Adaptive Randomization", Riviere Marie-Karelle et al. (2016) <doi:10.1177/0962280216631763>.
      0 references

      Identifiers

      0 references